Blockade of FGF signaling: therapeutic promise for ovarian cancer
- PMID: 20686363
- DOI: 10.4161/cbt.10.5.13023
Blockade of FGF signaling: therapeutic promise for ovarian cancer
Comment on
-
Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.Cancer Biol Ther. 2010 Sep 1;10(5):495-504. doi: 10.4161/cbt.10.5.12585. Epub 2010 Sep 4. Cancer Biol Ther. 2010. PMID: 20595807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical